Reproduction after breast cancer.

Zervoudis S; Iatrakis G; Navrozoglou I

首页> 外文期刊>Best practice & research:Clinical obstetrics & gynaecology >Reproduction after breast cancer.

【24h】

Reproduction after breast cancer.

机译：乳腺癌后的生殖。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Breast cancer is the most frequently occurring cancer in women of developed countries, and as a result of new developments in breast cancer treatment, more women are cured after being diagnosed with this disease. It is important that fertility preservation strategies are addressed before chemotherapy, because chemotherapy may induce premature ovarian failure (depending on the woman's age, the drugs used, the dosage and duration of treatment). Among possible solutions are embryos or oocytes cryopreservation, ovarian tissue cryopreservation-freezing with a subsequent orthotopic and heterotopic autotransplantation, whole ovary cryopreservation, ovarian suppression with gonadotropin-releasing hormone (GnRH) analogues, which inhibit ovarian follicular depletion induced by chemotherapeutic agents and in vitro fertilisation (IVF) after ovulation induction with aromatase inhibitors or tamoxifen.

机译：乳腺癌是发达国家妇女中最常见的癌症，并且由于乳腺癌治疗的新发展，更多的妇女被诊断出患有这种疾病后可以治愈。化疗之前必须解决生育保留策略，因为化疗可能会导致卵巢早衰（取决于女性的年龄，所用药物，治疗的剂量和持续时间），这一点很重要。可能的解决方案包括胚胎或卵母细胞冷冻保存，卵巢组织冷冻保存及随后的原位和异位自体移植，全卵巢冷冻保存，促性腺激素释放激素（GnRH）类似物对卵巢的抑制作用，这些抑制物可抑制化学治疗剂和体外诱导的卵泡消耗。用芳香酶抑制剂或他莫昔芬诱导排卵后进行受精（IVF）。

著录项

来源
《Best practice & research:Clinical obstetrics & gynaecology》 |2010年第1期|共6页
作者
Zervoudis S; Iatrakis G; Navrozoglou I;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学;
关键词

相似文献

外文文献
中文文献
专利

1. Reproduction after breast cancer. [J] . Zervoudis S, Iatrakis G, Navrozoglou I Best practice & research:Clinical obstetrics & gynaecology . 2010,第1期

机译：乳腺癌后的生殖。
2. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. [J] . Goldhirsch A, Glick JH, Gelber RD, Journal of Clinical Oncology . 2001,第18期

机译：会议重点：国际原发性乳腺癌治疗共识小组。第七届原发性乳腺癌辅助治疗国际会议。
3. Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer. [J] . Sugimachi K, Maehara Y, Akazawa K, Breast cancer research and treatment. . 1999,第2期

机译：丝裂霉素C，他莫昔芬和UFT的术后化学内分泌治疗对绝经前雌激素受体阳性的II期乳腺癌患者有效。 Nishinihon乳腺癌辅助治疗合作研究组。
4. Characterization of endogenous phosphorylation in p130Cas, an anti-estrogen resistance generating protein in human breast cancer. [C] . Giuseppe Infusini, Anthony Makkinje, David H. Perlman, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：P130CAs中内源性磷酸化的表征，人乳腺癌中抗雌激素产生蛋白质。
5. Expanding preventive breast cancer genetics: From high to moderate risk and from breast to pancreatic cancer. [D] . Young, Erin Lynn. 2016

机译：扩大预防性乳腺癌的遗传学：从高风险到中度风险，从乳腺癌到胰腺癌。
6. Educating women about breast cancer. An intervention for women with a family history of breast cancer. [O] . Ellen Warner, June C. Carroll, Ruth E. Heisey, 2003

机译：对妇女进行乳腺癌教育。对有乳腺癌家族史的妇女的干预。
7. Early breast cancer. Different aspects of combined treatment. New approaches in neoadjuvant treatment of early HER2-positive breast cancer. [O] . V. V. Sakaeva 2015

机译：早期乳腺癌。组合治疗的不同方面。早期海洋2阳性乳腺癌新辅助治疗的新方法。

Reproduction after breast cancer.

摘要

著录项

相似文献

相关主题

期刊订阅